Medial Patellofemoral Ligament Reconstruction for Knee Dislocation
(SHYFT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two approaches to addressing knee dislocation issues caused by patellofemoral instability (when the kneecap frequently shifts out of place). Researchers compare standard knee ligament reconstruction with a combined approach that includes an additional bone adjustment procedure. The goal is to determine which method better improves knee stability and patient satisfaction. Individuals with frequent kneecap dislocations might be suitable candidates for this study. As an unphased trial, it offers patients the chance to contribute to innovative research that could enhance future treatment options.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this technique is safe for knee dislocation?
Research has shown that surgery to repair the ligament on the inside of the knee (MPFL-R) is generally safe and well-tolerated. In past studies, only about 10.6% of patients experienced minor issues, such as mild knee pain, lingering instability, and a few minor infections.
When combined with tibial tubercle osteotomy (TTO), studies found similar safety outcomes. Adding TTO did not introduce major new safety concerns compared to MPFL-R alone. Overall, both treatments are considered safe for individuals with knee dislocation problems.12345Why are researchers excited about this trial?
Medial patellofemoral ligament reconstruction (MPFL-R) is unique because it specifically targets the stability of the kneecap, which is crucial for preventing dislocations. Unlike traditional treatments that often rely on physical therapy or bracing, MPFL-R surgically restores the ligament that naturally helps keep the kneecap in place. Researchers are particularly excited about the MPFL-R combined with tibial tubercle osteotomy (TTO) because this combined approach addresses both the soft tissue and structural alignment issues, potentially offering a more comprehensive solution to knee instability. This could lead to better long-term outcomes for patients with knee dislocations compared to current standard treatments.
What evidence suggests that this trial's treatments could be effective for knee dislocation?
This trial will compare two treatment approaches for knee dislocation. Research has shown that reconstructing the medial patellofemoral ligament (MPFL-R), one of the treatments in this trial, effectively stabilizes the knee and prevents the kneecap from slipping out of place. Studies have found that the chance of the kneecap dislocating again is as low as 1%, and the chance of the surgery not working is about 6.6%. Patients typically experience improved knee function and less pain after the surgery.
Another treatment arm in this trial involves MPFL-R combined with a procedure called tibial tubercle osteotomy (TTO). This combination often leads to better results for those with ongoing kneecap dislocation issues. The combined approach has a higher success rate without increasing the risk of complications. However, some studies found no major difference in patient satisfaction when comparing the combined surgery to MPFL-R alone.12567Who Is on the Research Team?
Laurie A Hiemstra, MD, PhD
Principal Investigator
University of Calgary
Are You a Good Fit for This Trial?
This trial is for young people aged 13-30 with recurrent knee cap dislocation and specific bone alignment issues (TT-TG ≥15mm on MRI or ≥18mm on CT). They must have mature bones, confirmed by x-rays. It's not for those with certain knee ratios, excessive femoral or tibial rotation, severe groove deformities needing surgery, advanced arthritis in the kneecap joint, cartilage restoration procedures, inability to do computer questionnaires or if pregnant.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either isolated MPFL-R or MPFL-R with TTO surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 6, 12, and 24 months post-operative
Long-term Follow-up
Participants continue to be monitored for long-term outcomes and complications
What Are the Treatments Tested in This Trial?
Interventions
- Medial patellofemoral ligament reconstruction
Medial patellofemoral ligament reconstruction is already approved in European Union, United States, Canada for the following indications:
- Patellar instability
- Recurrent patellar dislocation
- Patellar instability
- Recurrent patellar dislocation
- Patellar instability
- Recurrent patellar dislocation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Banff Sport Medicine Foundation
Lead Sponsor
ConMed Corporation
Industry Sponsor
CONMED Corporation
Industry Sponsor
Canadian Orthopaedic Foundation
Collaborator